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Objective: The aim of this study was to describe the ﬁve-year European experience of
retrograde percutaneous coronary interventions (PCI) revascularization for complex
chronic total occlusions (CTOs) of coronary arteries.
Background: Retrograde approach increases the success rate of percutaneous recan-
alization of complex CTOs of coronary arteries.
Methods: Demographic data, procedural outcomes and in-hospital clinical events
were collected on 1582 consecutive lesions of 1395 patients enrolled between January
2008 and December 2012 having retrograde CTO PCI at 44 European medical
centers by 45 experienced interventionalist operators. A revision of J-CTO score
proposed for antegrade lesions was used to better describe success according to lesion
difﬁculty.
Results: Patients mean age was 62.010.4 years, 88.5% were men, 17.6% had prior
coronary artery bypass surgery. The CTO target vessel was the right coronary artery
(70.4%), circumﬂex (7.8%), left anterior descending artery (20.3%), and left main
artery or by-pass graft (1.5%). The retrograde approach was used after prior failed
attempt in 43.5% of cases. During the procedure the retrograde approach was used as
ﬁrst line strategy in 76.2% of cases, while immediately after antegrade failed approach
in 23.8% of cases. Retrograde collateral vessels were septal (62.7%), epicardial (13.4%),
by-pass graft (3.9%) or missing information (20.0%). Technical success was 75.3%
(n¼1.191). The mean contrast volume and ﬂuoroscopy time were 396.3171.3 ml
and 69.834.1 mins, respectively. A major complication occurred in 16 patients
(1.0%). In multivariable analysis, age of the patient (per 10-year increase), lower
operator volume (<50, 50-100, >100), increased J-CTO score were signiﬁcantly
associated with increased technical failure, (p¼0.01, p<0.001, p<0.001), respectively.
Conclusion: In Europe among selected centers dedicated to CTO revascularization,
retrograde approach was performed over a 5-year period in 16.5% of these patients.
The number of retrograde procedures were exponentially increasing during the last 2
years and were associated with high success and low major complications rates.
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Myocardial Perfusion in Patients with Total Occlusion of a Single Coronary Artery with
and without Collateral Circulation
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Background: Previous studies that investigated the effects of coronary collateral cir-
culation on myocardial perfusion were compromised by inclusion of patients with
multivessel coronary artery disease, incomplete occlusion, prior myocardial infarction,
or a combination of these.
Aim of work: In this study we will investigate the relationship between angiographic
collateral circulation and myocardial perfusion in patients with total occlusion of a*Indicates iMPACT Trial Accepted for Oral Presentationsingle coronary artery, in the absence of myocardial infarction or signiﬁcant stenosis in
the other coronary arteries supplying the same myocardial territory.
Methods and Results: Forty patients underwent stress myocardial single photon
emission computed tomography within 90 days of angiography. Collateral circulation
was present in 24 patients (group A) and absent in 16 patients (group B). Reversible
perfusion defects were present in 22(91.7%) patients in group A and in 12(75%) in
group B, comparison between both groups came back statistically insigniﬁcant (p-value
¼ NS). Group A included 4(18.2%) patients with a small size defect (<5%), 9(40.9%)
patients with a moderate perfusion defect (5-10%) and 9(40.9%) patients with a large
perfusion defect (>10%); while group B had 2(16.6%) patients with small perfusion
defect, 5(41.6%) patients with a moderate perfusion defect and also 5(41.6%) patients
with a large perfusion defect, comparison between both groups came back statistically
insigniﬁcant (p-value ¼ NS). The mean exercise time for patients in group A was 6.9
0.92 minutes and their mean achieved peak METs was 7.350.35 METs. On the
other hand; the mean exercise time for patients in group B was 6.9 0.83 minutes and
their mean peak METs was 7.230.25 METs. Comparison between both groups also
appeared to be statistically insigniﬁcant (p-value ¼ NS).
Conclusion: In patients with a single-vessel total coronary occlusion and without
myocardial infarction, stress-induced myocardial ischemia is almost always present,
irrespective of presence or absence of angiographic collaterals. These data suggest that
coronary collaterals do not appear to protect against stress-induced perfusion defects.
Nevertheless collaterals in our study did not have any positive impact on the functional
capacity of patients, predicted by the analysis of exercise duration and achieved peak
METs.
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Background: There are limited data comparing angiographic and clinical outcomes of
re-stenotic stented chronic total occlusive (CTO) lesion successfully revascularized
with drug-eluting stents (DESs) with those of de novo CTO lesion.
Methods: The study population consisted of consecutive 269 CTO patients (pts) who
successfully treated with DESs between January 2004 and June 2010. A total 249 pts
with de novo CTO lesion and 20 pts with re-stenotic stented CTO lesion were
included for analysis. The 6-to-9 month angiographic and 2-year clinical outcomes
were compared between the 2 groups.
Results: The baseline clinical characteristics were similar between the two groups
except prior myocardial infarction, LDL-cholesterol level, number of total implanted
stent and use of cilostazol. Angiographic outcomes at 6-to-9 months were similar
between the two groups. At 2-year follow-up, the incidence of major clinical outcomes
including all death, any myocardial infarction, any revascularization, target lesion and
vessel revascularization (TLR and TVR) and major adverse cardiac events (MACEs)
were similar between the two groups (Table). Further, even after adjustment of
baseline differences with multivariate analysis adjusted by age, gender, dyslipidemia,
LVEF, Lefevre classiﬁcation, all the major clinical outcomes were similar between the
two groups.
Conclusion: In our study, there were no difference in 6-to-9 month angiographic and
2-year clinical outcomes between pts with stented and de novo CTO lesions once the
CTO pts were successfully treated with DESs.
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Background: There is limited evidence regarding predictors associated with clinical
outcomes of patients with chronic total occlusion (CTO) successfully treated with
drug-eluting stents (DESs).
Methods: We investigated the 249 patients (pts) with de novo CTO lesions suc-
cessfully treated with DESs from 2004 to 2010. All major adverse cardiovascular
events (ALL-MACEs) were deﬁned as composite of total death, any myocardial
infarction (MI), target vessel revascularization (TVR) and non-target vessel revas-
cularization. The association of ALL-MACEs with clinical, biochemical and pro-
cedural variables including age, male gender, hypertension, diabetes mellitus,
smoking, hyperlipidemia, acute MI, multi-vessel disease, left main involvement,
prior PCI, cilostazol, left ventricular ejection fraction <30 %, Hemoglobin level,
Creatinine level, LDL-cholesterol<100 mg/dL, Glycated hemoglobin<7.0 %, High
sensivity-CRP, number of total stents, IVUS-guided PCI, adjuvant ballooning was
examined.
Results: The 12-month follow-up has been performed in the 242 of 249 pts (97.2%).
The incidence of ALL-MACEs was the 40 of 242 patients (16.5%). Multivariate
logistic regression was used to identify predictors affecting 1-year ALL-MACE. Left
main involvement was signiﬁcantly associated with 1-year ALL-MACEs and prior
PCI history had a trend to be associated with 1-year ALL-MACEs (Table).
Conclusion: In our study, left main involvement was an important independent
predictor associated with 1-year MACE following successful CTO intervention with
DES.CRT-141
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Background: Myocardial infarction (MI) is known to be associated with increased
adverse clinical outcomes in coronary artery diseases. The impact of percutaneous
coronary intervention (PCI) for CTO in patients with myocardial infarction is not
clear. We evaluated the 12-month clinical outcomes between PCI and optimal medical
therapy (OMT) for CTO lesions in MI patients.
Methods: A total of 143 consecutive CTO patients who were admitted for MI were
divided into 2 groups according to treatment strategy; PCI group (n¼68) and OMT
group (n¼75). 12-month clinical outcomes were compared between the two groups.
Results: At baseline, patients in the OMT group showed a higher prevalence of
elderly, hyperlipidemia, peripheral vascular disease, de novo lesion, non-CTO pro-
cedure, multivessel disease, and LCX-CTO. Patients in the PCI group showed a
higher prevalence of prior MI, prior PTCA, and LAD-CTO lesion. Clinical out-
comes at 12 months showed lower mortality and lower rates of recurrent MI in the
PCI group. After baseline adjustment by multivariate analysis, however, there was no
difference.
Conclusion: In our study, intervention shows a possibility of being a favorable choice
of therapy for CTO lesions in MI patients in terms of 12-month mortality and MI-
related morbidity. Long-term follow up with a larger study population will be
necessary for further determination of the beneﬁt and risks of interventional therapy in
CTO patients.
